HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

octadeca(lysine)

Also Known As:

Lys(18); octadeca(L-lysine)

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Polylysine: 237
    - octadeca(lysine): 4
- Amino Acids: 30675
  - Basic Amino Acids: 178
    - Lysine: 6737
      - Polylysine: 237
        octadeca(lysine): 4
  - Diamino Amino Acids: 101
    - Lysine: 6737
      - Polylysine: 237
        octadeca(lysine): 4

Experts

1.	Schwaiger, Markus: 4 articles (03/2009 - 05/2004)
2.	Herz, Michael: 3 articles (04/2006 - 05/2004)
3.	Poethko, Thorsten: 3 articles (04/2006 - 05/2004)
4.	Schottelius, Margret: 3 articles (04/2006 - 05/2004)
5.	Kessler, Horst: 2 articles (06/2004 - 05/2004)
6.	Wester, Hans-Jürgen: 2 articles (06/2004 - 05/2004)
7.	Astner, Sabrina T: 1 article (03/2009)
8.	Beer, Ambros J: 1 article (03/2009)
9.	Bundschuh, Ralph A: 1 article (03/2009)
10.	Essler, Markus: 1 article (03/2009)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2004 - "How-ever, only Cel-S-Dpr([(18)F]FBOA)TOCA and Gluc-S-Dpr([(18)F]FP)TOCA (tumor: 15.1 +/- 1.5% of injected dose/g) with its very low accumulation in all of the nontarget organs showed improved tumor:organ ratios compared with Gluc-Lys([(18)F]FP)TOCA. " 04/01/2006 - "Twenty-five patients with different sstr-positive tumors were included in the study and were injected with 105 +/- 50 MBq Gluc-Lys([(18)F]FP)-TOCA. " 03/15/2009 - "Especially in patients with recurrent tumors after surgery, Gluc-Lys[(18)F]-TOCA PET improves the accuracy of GTV delineation." 04/01/2006 - "Gluc-Lys([(18)F]FP)-TOCA PET allows a fast, high- contrast imaging of sstr-positive tumors. " 04/01/2006 - "Gluc-Lys([(18)F]FP)-TOCA showed a fast and intense tumor accumulation as well as a rapid clearance from blood serum (biexponential elimination, with the half-lives of the initial and the terminal elimination phase calculated as t(1/2)(1) = 2.3 +/- 1.3 min and t(1/2)(2) = 26.4 +/- 14.6 min, respectively). "
2.	Glomus Tumor (Glomus Tumors) 03/15/2009 - "Nine patients with a total of 11 glomus tumors underwent PET either with Gluc-Lys[(18)F]-TOCA or with (68)Ga-DOTATOC (in 1 case). " 03/15/2009 - "To assess a threshold for Gluc-Lys[(18)F]-TOCA positron emission tomography (PET) in target volume delineation of glomus tumors in the skull base and to compare with MRI-based target volume delineation. " 03/15/2009 - "In patients with glomus tumors, Gluc-Lys[(18)F]-TOCA PET helps to reduce interobserver variability if an appropriate threshold for tumor segmentation has been determined for institutional conditions. " 03/15/2009 - "Assessment of tumor volumes in skull base glomus tumors using Gluc-Lys[(18)F]-TOCA positron emission tomography."

Related Drugs and Biologics

1.	Somatostatin Receptors (Somatostatin Receptor)
2.	Octreotide (Sandostatin)
3.	Pentetic Acid (DTPA)
4.	Tyr(3)- octreotate